Skip to main content
. 2019 Sep 14;25:44. doi: 10.1186/s10020-019-0111-4

Fig. 2.

Fig. 2

PRSS1_R116C mutation promotes the malignant phenotype of PANC-1 cells. a. The transwell chamber system was applied to assess the effect of PRSS1 wild type/R116C mutant overexpression on PANC-1 cell migration (converted microscope, 200×); b. The matrigel assay was performed to evaluate the effect of PRSS1 wild type/R116C mutant overexpression on PANC-1 cell invasion; c. CCK8 assay was used to measure PANC-1 cell proliferation; d. Effect of PRSS1 wild type/R116C mutant overexpression on PANC-1 cell cycle distribution; e. Flow cytometry was employed to measure the effect of PRSS1 wild type/R116C mutant on PANC-1 cell proliferation; f. R116C mutation prominently increased ERK and VEGFR2 expression in pancreatic cancer